ESTRO 2025 - Abstract Book

S2655

Physics - Detectors, dose measurement and phantoms

ESTRO 2025

Conclusion: These preliminary results demonstrated that out-of-field lymphoid organ doses can be assessed from in-vivo RPLGD measurement at patient skin. Our investigations are ongoing to collect more data on patients and to improve our model.

Keywords: In vivo measurement, out-of-field, RPLGD

References: [1] Dawood A et al. Low dose ionizing radiation and the immune response: what is the role of non-targeted effects? Int J Radiat Biol (2021). doi: 10.1080/09553002.2021.1962572 [2] J.M. Bordy, etal. (2013). Radiotherapy out-of-field dosimetry: Experimental and computational results for photons in a water tank. Radiation Measurements . doi:https://doi.org/10.1016/j.radmeas.2013.06.010 [3] Kry SF, et al. (2017). AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phy . [4] P E Wesolowska et al. (2017) Characterization of three solid state dosimetry systems for use in high energy photon dosimetry audits in radiotherapy Radiation Measurements, doi.org/10.1016/j.radmeas.2017.04.017.